References
- Bienertova-Vasku J, Sana J, Slaby O. The role of microRNAs in mitochondria in cancer. Cancer Lett 2013; 336: 1-7. doi: 10.1016/j.canlet.2013.05.001
- Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol 2012; 6: 590-610. doi: 10.1016/j.molonc.2012.09.006
- Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res 2011; 39: 6845-53. doi: 10.1093/nar/gkr330
- Zhang X, Zuo X, Yang B, Li Z, Xue Y, zhuo Y, et al. MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell 2014; 158: 607-19. doi: 10.1016/j.cell.2014.05.047
- Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-54. doi: 10.1016/0092-8674(93)90529-Y
- Wang JK, Wang Z, Li G. MicroRNA-125 in immunity and cancer. Cancer Lett 2019; 454: 134-45. doi: 10.1016/j.canlet.2019.04.015
- Macgregor-Das AM, Das S. A microRNA’s journey to the center of the mitochondria. Am J Physiol Circ Physiol 2018; 315: H 206-H215. doi: 10.1152/ ajpheart.00714.2017
- Fiore D, Donnrumma E, Roscigno G, Iaboni M, Russo V, Affinito A, et al. miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS. Oncotarget 2016; 7: 19531-47. doi: 10.18632/oncotarget.6968
- Pekarsky Y, Balatti V, Palamarchuk A, Rizzotto L, Veneziano D, Bigita G, et al. Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer. Proc Natl Acad Sci 2016; 113: 5071-76. doi: 10.1073/ pnas.1604266113
- Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, et al. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene 2013; 32: 4001-8. doi: 10.1038/ onc.2012.410
- Roscigno G, Puoti I, Giordano I, Donnarumma E, Russo V, Affinito A, et al. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer. Oncotarget 2017; 8: 19507-21. doi: 10.18632/oncotarget.14470
- Zhang J, He J, Zhang L. The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signaling. Biomed Pharmacother 2018; 106: 3542. doi: 10.1016/j.biopha.2018.06.099
- Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 2019; 20: 21-37. doi: 10.1038/s41580-018-0045-7
- Ingenito F, Roscigno G, Affinito A, Nuzzo S, Scognamiglio I, Quintavalle C, et al. The role of exo-miRNAs in cancer: a focus on therapeutic and diagnostic applications. Int J Mol Sci 2019; 20: 4687. doi: 10.3390/ ijms20194687
- Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA, Shearwood AMJ, et al. The human mitochondrial transcriptome. Cell 2011; 146: 645-58. doi: 10.1016/j.cell.2011.06.051
- Breving K, Esquela-Kerscher A. The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol 2010; 42: 1316-29. doi: 10.1016/j.biocel.2009.09.016
- Tétreault N, De Guire V. miRNAs: Their discovery, biogenesis and mechanism of action. Clin Biochem 2013; 46: 842-5. doi: 10.1016/j.clinbiochem.2013.02.009
- Xiong Y, Wang Y, Wang L, Huang Y, Xu Y, Xu L. et al. MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells. J Cancer 2018; 9: 2147-59. doi: 10.7150/jca.25006
- Zhu L, Xue F, Xu X, Xu J, Hu S, Liu S, et al. MicroRNA-198 inhibition of HGF/c-MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non-small-cell lung cancer. J Cell Biochem 2018; 119: 7873-86. doi: 10.1002/jcb.27204
- Otto T, Candido SV, Pilarz MS, Sicinska E, Bronson RT, Bowden M, et al. Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit. Proc Natl Acad Sci 2017; 114: 10660-5. doi: 10.1073/ pnas.1702914114
- Wen X, Han XR, Wang YJ, Wang S, Shen M, Zhang ZF, et al. MicroRNA-421 suppresses the apoptosis and autophagy of hippocampal neurons in epilepsy mice model by inhibition of the TLR/MYD88 pathway. J Cell Physiol 2018; 233: 7022-34. doi: 10.1002/jcp.26498
- Yang T, Ge B. miRNAs in immune responses to Mycobacterium tuberculosis infection. Cancer Lett 2018; 431: 22-30. doi: 10.1016/j.canlet.2018.05.028
- Rosas-Hernandez H, Chigurupati S, Raymick J, Robinson B, Cuevas E, Hanig J, et al. Identification of altered microRNAs in serum of a mouse model of Parkinson’s disease. Neurosci Lett 2018; 687: 1-9. doi: 10.1016/j. neulet.2018.07.022
- Islas JF, Moreno-Cuevas JE. A MicroRNA perspective on cardiovascular development and diseases: an update. Int J Mol Sci 2018; 19: 2075. doi: 10.3390/ijms19072075
- Hosseinahli N, Aghapour M, Duijf PHG, Baradaran B. Treating cancer with microRNA replacement therapy: a literature review. J Cell Physiol 2018; 233: 5574-88. doi: 10.1002/jcp.26514
- Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer - a brief overview. Adv Biol Regul 2015; 57: 1-9. doi: 10.1016/j. jbior.2014.09.013
- Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis 2012; 33: 1126-33. doi: 10.1093/carcin/bgs140
- Tang Q, Ouyang H, He D, Yu C, Tang G. MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer. Artif Cells, Nanomedicine, Biotechnol 2019; 47: 2800-9. doi: 10.1080/21691401.2019.1638791
- Geiger J, Dalgaard LT. Interplay of mitochondrial metabolism and microRNAs. Cell Mol Life Sci 2017; 74: 631-46. doi: 10.1007/s00018-016-2342-7
- Das S, Kohr M, Dunkerly-Eyring B, Lee DI, Bedja D, Kent OA, et al. Divergent Effects of miR-181 Family members on myocardial function through protective cytosolic and detrimental mitochondrial microRNA targets. J Am Heart Assoc 2017; 6: 1-17. doi: 10.1161/JAHA.116.004694
- Paramasivam A, Vijayashree Priyadharsini J. MitomiRs: new emerging microRNAs in mitochondrial dysfunction and cardiovascular disease. Hypertens Res 2020; 43: 851-3. doi: 10.1038/s41440-020-0423-3
- Duarte FV, Palmeira CM, Rolo AP. The role of microRNAs in mitochondria: small players acting wide. Genes 2014; 5: 865-86. doi: 10.3390/ genes5040865
- Shinde S, Bhadra U. A complex genome-microRNA interplay in human mitochondria. Biomed Res Int 2015; 2015: 1-13. doi: 10.1155/2015/206382
- Bandiera S, Matégot R, Girard M, Demongeot J, Henrion-Caude A. MitomiRs delineating the intracellular localization of microRNAs at mitochondria. Free Radic Biol Med 2013; 64: 12-19. doi: 10.1016/j.freeradbiomed.2013.06.013
- Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X. PremicroRNA and mature microRNA in human mitochondria. PLoS One 2011; 6: e20220. doi: 10.1371/journal.pone.0020220
- Latronico MVG, Condorelli G. The might of microRNA in mitochondria. Circ Res 2012; 110: 1540-2. doi: 10.1161/CIRCRESAHA.112.271312
- Sripada L, Tomar D, Prajapati P, Singh R, Singh AK, Singh R. Systematic analysis of small RNAs associated with human mitochondria by deep sequencing: detailed analysis of mitochondrial associated miRNA. PLoS One 2012; 7: e44873. doi: 10.1371/journal.pone.0044873
- Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA, Shearwood AMJ. The human mitochondrial transcriptome. Cell 2011; 146: 645-58. doi: 10.1016/j.cell.2011.06.051
- Jagannathan R, Thapa D, Nichols CE, Shepherd DL, Stricker JC, Croston TL, et al. Translational regulation of the mitochondrial genome following redistribution of mitochondrial microRNA in the diabetic heart. Circ Cardiovasc Genet 2015; 8: 785-802.
- Bandiera S, Rüberg S, Girard M, Cagnard N, Hanein S, Chretien D, et al. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One 2011; 6: e20746. doi: 10.1371/journal.pone.0020746
- Fan S, Tian T, Chen W, Lv X, Lei X, Zhang H, et al. Mitochondrial miRNA determines chemoresistance by reprogramming metabolism and regulating mitochondrial transcription. Cancer Res 2019; 79: 1069-84. doi: 10.1158/0008-5472.CAN-18-2505
- Srinivasan H, Das S. Mitochondrial miRNA (MitomiR): a new player in cardiovascular health. Can J Physiol Pharmacol 2015; 93: 855-61. doi: 10.1139/cjpp-2014-0500
- Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol Mech Dis 2014; 9: 287-314. doi: 10.1146/annurev-pathol-012513-104715
- Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19: 586-93. doi: 10.1038/nsmb.2296
- Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol 2019; 20: 5-20. doi: 10.1038/s41580-018-0059-1
- Song R, Hu XQ, Zhang L. Mitochondrial miRNA in cardiovascular function and disease. Cells 2019; 8: 1475. doi: 10.3390/cells8121475
- Geiger J, Dalgaard LT. Interplay of mitochondrial metabolism and microRNAs. Cell Mol Life Sci 2017; 74: 631-646. doi: 10.1007/s00018-016-2342-7
- Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, et al. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res 2012; 110: 1596-603. doi: 10.1161/CIRCRESAHA.112.267732
- Shepherd DL, Hathaway QC, Pinti MV, Nichols CE, Durr AJ, Sreekumar S, et al. Exploring the mitochondrial microRNA import pathway through Polynucleotide Phosphorylase (PNPase). J Mol Cell Cardiol 2017; 110: 1525. doi: 10.1016/j.yjmcc.2017.06.012
- Chan DC. Fusion and fission: Interlinked processes critical for mitochondrial health. Annu Rev Genet 2012; 46: 265-87. doi: 10.1146/annurevgenet-110410-132529
- Kushnareva Y, Newmeyer D. Bioenergetics and cell death. Ann N Y Acad Sci 2010; 1201: 50-7. doi: 10.1111/J.1749-6632.2010.05633.X
- Hudson G, Gomez-Duran A, Wilson IJ, Chinnery PF. Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases. PLoS Genet 2014; 10: e1004369. doi: 10.1371/journal.pgen.1004369
- Dowling DK. Evolutionary perspectives on the links between mitochondrial genotype and disease phenotype. Biochim Biophys Acta - Gen Subj 2014; 1840: 1393-403. doi: 10.1016/j.bbagen.2013.11.013
- Wagner GR, Payne RM. Widespread and enzyme-independent Nϵacetylation and Nϵ-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J Biol Chem 2013; 288: 29036-45. doi: 10.1074/ jbc.M113.486753
- Pan T. N6-methyl-adenosine modification in messenger and long non-coding RNA. Trends Biochem Sci 2013; 38: 204-9. doi: 10.1016/j. tibs.2012.12.006
- Li K, Zhang J, Yu J, Liu B, Guo Y, et al. MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4. J Biol Chem 2015; 290: 8185-95. doi: 10.1074/jbc.M114.633990
- Brunette TJ, Permeggiani F, Huand PS, Bhabha G, Ekiert DC, Tsutakawa SE, et al. Exploring the repeat protein universe through computational protein design. Nature 2015; 528: 580-4. doi: 10.1038/nature16162
- Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, et al. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 2012; 17: 410-23. doi: 10.1007/s10495-011-0683-0
- Carrer M, Liu N, Grueter CE, Williams AH, Frisard MI, Hulver MW, et al. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc Natl Acad Sci 2012; 109: 15330-5. doi: 10.1073/pnas.1207605109
- Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762-5. doi: 10.1038/ nature07823
- Jeong JH, Cheol Kang Y, Piao Y, Kang S, Pak YK. miR-24-mediated knockdown of H2AX damages mitochondria and the insulin signaling pathway. Exp Mol Med 2017; 49: e313. doi: 10.1038/emm.2016.174
- Serguienko A, Grad I, Wennerstrom A, Meza-Zepeda LA, Thiede B, Stratford EW, et al. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA. Oncotarget 2015; 6: 2451-65. doi: 10.18632/oncotarget.3235
- Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S, et al. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma. Cancer Sci 2013; 104: 1411-9. doi 10.1111/ cas.12240
- Chen Y, Zhou Y, Han F, Zhao Y, Tu M, Wang Y, et al. A novel miR-1291-ERRαCPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis. Theranostics 2020; 10: 7193-210. doi: 10.7150/thno.44877
- Tu MJ, Duan Z, Liu Z, Zhang C, Bold RJ, Gonzalez FJ, et al. MicroRNA-1291-5p sensitizes pancreatic carcinoma cells to arginine deprivation and chemotherapy through the regulation of arginolysis and glycolysis. Mol Pharmacol 2020; 98: 686-94. doi: 10.1124/molpharm.120.000130
- Zhu H, Xue H, Jin QH, Guo J, Chen YD. MiR-138 protects cardiac cells against hypoxia through modulation of glucose metabolism by targetting pyruvate dehydrogenase kinase 1. Biosci Rep 2017; 37: 1-9. doi: 10.1042/ BSR20170296
- Ju J, Xiao D, Shen N, Zhou T, Che H, Li X, et al. miR-150 regulates glucose utilization through targeting GLUT4 in insulin-resistant cardiomyocytes. Acta Biochim Biophys Sin (Shanghai) 2020; 52: 1111-9. doi: 10.1093/ abbs/gmaa094
- Li SJ, Liu HL, Tang SL, Li XJ, Wang XY. MicroRNA-150 regulates glycolysis by targeting von Hippel-Lindau in glioma cells. Am J Transl Res 2017; 9: 1058-66.
- Guo W, Qiu Z, Wang Z, Wang Q, Tan N, Chen T, et al. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology 2015; 62: 1132-44. doi: 10.1002/hep.27929
- Esteves JV, Yonamine CY, Pinto-Junior DC, Gerlinger-Romero F, Enguita FJ, Machado UF. Diabetes modulates microRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p expression in muscle: Possible role in GLUT4 and HK2 repression. Front Endocrinol 2018; 9: 1-12. doi: 10.3389/fendo.2018.00536
- Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR-29a and miR-29b contribute to pancreatic β-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 2011; 31: 3182-94. doi: 10.1128/ MCB.01433-10
- Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011; 478: 404-7. doi: 10.1038/ nature10486
- Chen L, Hou J, Ye L, Chen Y, Cui J, Tian W, et al. MicroRNA-143 regulates adipogenesis by modulating the MAP2K5-ERK5 signaling. Sci Rep 2015; 4: 3819. doi: 10.1038/srep03819
- Ye Q, Zhao X, Xu K, Li Q, Cheng J, Gao Y, et al. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome. Gene 2013; 528: 132-8. doi: 10.1016/j.gene.2013.07.036
- Civelek M, Hagopian R, Pan C, Che N, Yang W, Kayne PS, et al. Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits. Hum Mol Genet 2013; 22: 3023-37. doi: 10.1093/ hmg/ddt159
- Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W, et al. Phosphoglucose isomerase/autocrine motility factor mediates epithelialmesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res 2011; 71: 3400-9. doi: 10.1158/0008-5472.CAN-10-0965
- Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranji O, Gioio AE, Kaplan BB. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 2008; 28: 12581-90. doi: 10.1523/JNEUROSCI.3338-08.2008
- Li P, Jiao J, Gao G, Prabhakar BS. Control of mitochondrial activity by miR-NAs. J Cell Biochem 2012; 113: 1104-10. doi: 10.1002/jcb.24004
- Barman RK, Saha S, Das S. Prediction of interactions between viral and host proteins using supervised machine learning methods. PLoS One 2014; 9: e112034. doi: 10.1371/journal.pone.0112034
- Chen, H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010; 141: 280-9. doi: 10.1016/j. cell.2010.02.026
- Colleoni F, Padmanabhan N, Wung HW, Watson ED, Cetin I, Tissot van Patot M, et al. Suppression of mitochondrial electron transport chain function in the hypoxic human placenta: a role for miRNA-210 and protein synthesis inhibition. PLoS One 2013; 8: e55194. doi: 10.1371/journal.pone.0055194
- Nishi H, Ono K, Iwanaga Y, Horie T, Nagao T, Takemura G, et al. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem 2010; 285: 4920-30. doi: 10.1074/jbc.M109.082610
- Tomasetti M, Neuzil J, Dong L. MicroRNAs as regulators of mitochondrial function: role in cancer suppression. Biochim Biophys Acta 2014; 1840: 1441-53. doi: 10.1016/j.bbagen.2013.09.002
- Zheng S, Li Y, Zhang Y, Li X, Tang H. MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res 2011; 89: 219-226. doi: 10.1016/j.antiviral.2011.01.008
- Qiao A, Khechaduri A, Mutharasan RK, Wu R, Nagpal V, Ardehali H. MicroRNA-210 Decreases heme levels by targeting ferrochelatase in cardiomyocytes. J Am Heart Assoc 2013; 2: 1-12. doi: 10.1161/ JAHA.113.000121
- Kurtz CL, Peck BCE, Fannin EE, Beysen C, Miao J, Landstreet SR, et al. MicroRNA-29 Fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes. Diabetes 2014; 63: 3141-8. doi: 10.2337/db13-1015
- Li X, Wang FS, Wu ZY, Lin JL, Lan WB, Lin JH. MicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cells. Neoplasma 2014; 61: 265-73. doi: 10.4149/neo_2014_034
- Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, et al. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res 2012; 110: 1596-603. doi: 10.1161/CIRCRESAHA.112.267732
- Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-74. doi: 10.1016/j.cell.2011.02.013
- Zhong Z, Yu J, Virshup DM, Madan B. Wnts and the hallmarks of cancer. Cancer Metastasis Rev 2020; 39: 625-45. doi: 10.1007/S10555-020-09887-6
- Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep 2015; 42: 841-51. doi: 10.1007/s11033-015-3858-x
- Zheng J. Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol Lett 2012; 4: 1151-7. doi: 10.3892/ ol.2012.928
- Fogg VC, Lanning NJ, MacKeigan JP. Mitochondria in cancer: at the crossroads of life and death. Chin J Cancer 2011; 30: 526-39. doi: 10.5732/ cjc.011.10018
- Mogilyansky E, Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 2013; 20: 1603-14. doi: 10.1038/cdd.2013.125
- Chen B, Li H, Yenh X, Yang P, Liu X, Yhao X, et al. Roles of microRNA on cancer cell metabolism. J Transl Med 2012; 10: 228. doi: 10.1186/14795876-10-228
- Li L, Yuan L, Luo J, Gao J, Guo J, Xie X. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 2013; 13: 109-17. doi: 10.1007/s10238-012-0186-5
- Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, et al. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer 2011; 105: 296-303. doi: 10.1007/s10238-012-0186-5
- Zhang L, Liao Y, Tang L. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res 2019; 38: 1-13. doi: 10.1186/S13046-019-1059-5
- Endo K, Naito Y, Ji X, Nakanishi M, Noguchi T, Goto Y, et al. MicroRNA 210 as a biomarker for congestive heart failure. Biol Pharm Bull 2013; 36: 4854. doi: 10.1248/bpb.b12-00578
- Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Nonlinear partial differential equations and applications: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 2002; 99: 15524-9. doi: 10.1073/pnas.242606799
- Gao S, Chen C, Wu J, Tan Y, Yu K, Xing CY, et al. Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide. Biochem Biophys Res Commun 2010; 403: 203-8. doi: 10.1016/J.BBRC.2010.10.137
- Siengdee P, Trakooljul N, Murani E, Schwerin M, Wimmers K, Ponsuksili S. MicroRNAs regulate cellular ATP levels by targeting mitochondrial energy metabolism genes during C2C12 myoblast differentiation. 2015; doi:10.1371/journal.pone.0127850. doi:10.1371/journal.pone.0127850.
- Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y, et al. MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem 2012; 287: 23227-23235. doi: 10.1074/jbc.M112.373084
- Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, Liang S, et al. A novel miR-155/ miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J 2012; 31: 1985-98. doi: 10.1038/emboj.2012.45
- Sun Y, Zhao X, Zhou Y, Hu Y. miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect. Oncol Rep 2012; 28: 1346-52. doi: 10.3892/or.2012.1958
- Kefas B, Comeau L, Erdle N, Montgomery E, Amos S, Purow B. Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. Neuro Oncol 2010; 12: 1102-12. doi: 10.1093/ neuonc/noq080
- Olive V, Jiang I, He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010; 42: 1348-54. doi: 10.1016/j. biocel.2010.03.004
- Zhuang X, Chen Y, Wu Z, Xu Q, Chen M, Shao M, et al. Mitochondrial miR181a-5p promotes glucose metabolism reprogramming in liver cancer by regulating the electron transport chain. Carcinogenesis 2020; 41: 972-83. doi: 10.1093/CARCIN/BGZ174
- Qin Q, Furong W, Baosheng L. Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res 2014; 33: 50. doi: 10.1186/17569966-33-50
- Gee HE. Camps C, Buffa FM, Patiar S, Winter SC, Betts G, et al. hsamiR-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010; 116: 2148-58. doi: 10.1002/cncr.25009
- Puisségur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 2011; 18: 465-78. doi: 10.1038/ cdd.2010.119
- Yao J, Zhou E, Wang Y, Xu F, Zhang D, Zhong D. microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer. DNA Cell Biol 2014; 33: 291-300. doi: 10.1089/dna.2013.2132
- Mi Y, Zhang D, Jiang W, Weng J, Zhou C, Huang K, et al. miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. Cancer Lett 2017; 389: 11-22. doi: 10.1016/j.canlet.2016.12.033
- Zhu N, Zang D, Xie H, Zhou Z, Chen H, Hu T, et al. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem 2011; 351: 157-64. doi: 10.1007/s11010-011-0723-7
- Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci 2008; 105: 15535-40. doi: 10.1073/pnas.0808266105
- Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K. et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 2012; 107: 700-6. doi: 10.1038/bjc.2012.330
- Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008; 373: 607-12. doi: 10.1016/j. bbrc.2008.06.090
- Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, et al. miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 2013; 8: e56824. doi: 10.1371/journal.pone.0056824
- Shen WF, Hu YL, Uttarwar L, Passegue E, Largman C. MicroRNA-126 regulates HOXA9 by binding to the homeobox. Mol Cell Biol 2008; 28: 4609-19. doi: 10.1128/MCB.01652-07
- Zhang J, Du YY, Lin, Y, Chen Y, Yang L, Wang H, et al. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 2008; 377: 136-40. doi: 10.1016/j.bbrc.2008.09.089
- Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Tuasa Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 2011; 6: e16617. doi: 10.1371/journal.pone.0016617
- Miko E, Margitai Z, Czimmerer Z, Varkonyi I, Dezso B, Lanyi A, et al. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. FEBS Lett 2011; 585: 1191-1196. doi: 10.1016/j.febslet.2011.03.039
- Gee HE, Ivan C, Calin GA, Ivan M. HypoxamiRs and cancer: From biology to targeted therapy. Antioxid Redox Signal 2014; 21: 1220-38. doi: 10.1089/ ars.2013.5639
- Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbson DL, Baird BN, et al. miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res 2011; 9: 25-35. doi: 10.1158/1541-7786.MCR-10-0497
- Rasheed SAK, Teo CR, Beillard EJ, Voorhoeve PM, Casey PJ. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. J Biol Chem 2013; 288: 7986-95. doi: 10.1074/jbc.M112.437749
- Renčelj A, Škrlep M, Čandek-Potokar M, Dovč P. Tissue specific splicing of pre-mRNA porcine mitochondrial transcription factor A. Czech J Anim Sci 2018; 63: 43-50. doi: 10.17221/29/2017-CJAS
- Han B, Izumi H, Yasuniwa Y, Akiyama M, Yamaguchi T, Fujimoto N, et al. Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth. Biochem Biophys Res Commun 2011; 408: 45-51. doi: 10.1016/j.bbrc.2011.03.114
- Izreig S, Samborska B, Johnson RM, Sergushichev A, Ma EH, Lussier C, et al. The miR-17-92 microRNA cluster is a global regulator of tumor metabolism. Cell Rep 2016; 16: 1915-28. doi: 10.1016/j.celrep.2016.07.036